PPARG and keloid: With troglitazone, a widely used PPAR-γ agonist, Zhu et al. demonstrated its inhibitory role in collagen synthesis in human keloid fibroblasts by suppressing the effect on TGF-β1 signaling through the upregulation of miR-92b [48, 49].